— Know what they know.
Not Investment Advice

ANIP NASDAQ

ANI Pharmaceuticals, Inc.
1W: +4.0% 1M: +3.3% 3M: +6.4% YTD: +5.5% 1Y: +36.5% 3Y: +86.9% 5Y: +136.1%
$82.72
-0.05 (-0.06%)
After Hours: $78.25 (-4.47, -5.40%)
Weekly Expected Move ±4.2%
$71 $75 $78 $81 $85
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 62 · $1.9B mcap · 19M float · 1.89% daily turnover · Short 59% of daily vol

Cash Flow Trends

Operating Cash Flow
$185M +189.3% ▲
5Y CAGR: +64.7%
Capital Expenditures
$14M +18.4% ▲
5Y CAGR: -27.3%
Free Cash Flow
$171M +264.2% ▲
Dividends Paid
$1M +28.8% ▲
Buybacks
$12M -11.4% ▼
Net Change in Cash
$141M +284.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$43M-$48M$19M-$19M$78M
Depreciation & Amort.$47M$60M$60M$68M$91M
Stock-Based Comp.$10M$15M$21M$29M$38M
Change in Working Capital-$84K-$51M$25M-$11M-$7M
Other Non-Cash Items$5M$9M$7M$19M-$30M
Operating Cash Flow$3M-$31M$119M$64M$185M
— Investing Activities —
Capital Expenditures-$3M-$9M-$9M-$16M-$34M
Acquisitions (Net)-$84M-$33K$0-$401M$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$18M-$7M-$10M$13M$0
Investing Cash Flow-$105M-$16M-$19M-$405M-$34M
— Financing Activities —
Net Debt Issuance$99M-$3M-$3M$345M-$10M
Stock Repurchased-$890K-$2M-$5M-$11M-$12M
Dividends Paid-$190K-$2M-$2M-$2M-$1M
Other Financing$2M$1M-$4M-$68M-$26K
Financing Cash Flow$195M-$5M$67M$265M-$10M
Net Change in Cash$92M-$52M$168M-$76M$141M
Cash End of Period$105M$53M$221M$145M$286M
Free Cash Flow-$20M-$48M$100M$47M$171M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms